HIV molecular immunology database
Found 1 matching record:
HXB2 Location | Gag(162-172) | Gag Epitope Map
View variants at this location |
||||
---|---|---|---|---|---|---|
Epitope |
KAFSPEVIPMF
|
Epitope Alignment | ||||
Variants |
|
|||||
Epitope Name | KF11 | |||||
Species (MHC/HLA) | human(B*57:01) |
Showing 1 of 4 variants.
Variant ID. | 3183 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | KAFSPEiIPMF |
Mutations | V/I |
Epitope Location | V7I |
HXB2 Location | V167I |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | Flow cytometric T-cell cytokine assay |
Note | Epitope mutation, E|KAFSPEiIPMF|S, was seen for KF11 by 168 weeks post-infection in P1 who carried HLA alleles A*0101,A*0301,B*2705,B*5701 and by 301 weeks post-infection in P6 who carried HLA alleles A*0301,A*2402,B*3501,B*5701. |
Norstrom2012 Melissa M. Norström, Marcus Buggert, Johanna Tauriainen, Wendy Hartogensis, Mattia C. Prosperi, Mark A. Wallet, Frederick M. Hecht, Marco Salemi, and Annika C. Karlsson. Combination of Immune and Viral Factors Distinguishes Low-Risk Versus High-Risk HIV-1 Disease Progression in HLA-B*5701 Subjects. J. Virol., 86(18):9802-9816, Sep 2012. PubMed ID: 22761389. Show all entries for this paper.